NEOLEUKIN THERAPEUTICS INC(NASDAQ:NLTX) stock News

NLTX Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Seeking Alpha

Neoleukin Therapeutics announces 1-for-4 reverse stock split (NASDAQ:NLTX)

2 years ago - By: Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

2 years ago - By: Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

2 years ago - By: Benzinga - Mentions: DYAI ICU IPHA KRMD ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

2 years ago - By: Benzinga - Mentions: SSU ISPO MKUL RGP ...

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket

2 years ago - By: InvestorPlace - Mentions: ORTX WNW MKUL GROM ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: Seeking Alpha

Neoleukin Therapeutics announces 1-for-5 reverse stock split (NASDAQ:NLTX)

2 years ago - By: Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

2 years ago - By: Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

2 years ago - By: Kahn Swick & Foti, LLC

NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX

2 years ago - By: Brodsky & Smith LLC - Mentions: SCU PRDS AJX RITM

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)

2 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene

2 years ago - By: Brodsky & Smith LLC - Mentions: PRDS KLR AJX

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)

2 years ago - By: Halper Sadeh LLC

NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders

2 years ago - By: Seeking Alpha

Neoleukin jumps 7% on Neurogene merger (NASDAQ:NLTX)

2 years ago - By: Neoleukin Therapeutics, Inc.

Neurogene and Neoleukin Announce Definitive Merger Agreement

2 years ago - By: Neoleukin Therapeutics, Inc.

Neurogene and Neoleukin Announce Definitive Merger Agreement

2 years ago - By: InvestorPlace - Mentions: TTC BPTS BCAN ATXI ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

2 years ago - By: Seeking Alpha

Neoleukin Therapeutics to cut 70% workforce, CEO steps down (NASDAQ:NLTX)

2 years ago - By: Neoleukin Therapeutics, Inc.

Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

3 years ago - By: Neoleukin Therapeutics, Inc.

NEOLEUKIN THERAPEUTICS INC (NLTX) Stock News

NLTX Latest News, Press Relases and Analysis

Neoleukin Therapeutics announces 1-for-4 reverse stock split (NASDAQ:NLTX)

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why Orchard Therapeutics Shares Are Trading Higher By Around 95%; Here Are 20 Stocks Moving Premarket

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Neoleukin Therapeutics announces 1-for-5 reverse stock split (NASDAQ:NLTX)

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

Neoleukin Therapeutics Announces 1-for-5 Reverse Stock Split

NEOLEUKIN THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Neoleukin Therapeutics, Inc. - NLTX

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Sculptor Capital Management Inc. (NYSE – SCU), Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Great Ajax Corp. (NYSE – AJX)

Shareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Neoleukin Therapeutics, Inc. (Nasdaq - NLTX), Pardes Bioscience, Inc. (Nasdaq – PRDS), Kaleyra, Inc. (NYSE – KLR), Great Ajax Corp. (NYSE – AJX)

NLTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Neoleukin Therapeutics, Inc. Is Fair to Shareholders

Neoleukin jumps 7% on Neurogene merger (NASDAQ:NLTX)

Neurogene and Neoleukin Announce Definitive Merger Agreement

Neurogene and Neoleukin Announce Definitive Merger Agreement

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Neoleukin Therapeutics to cut 70% workforce, CEO steps down (NASDAQ:NLTX)

Neoleukin Therapeutics Provides Strategic Update and Announces Restructuring and Leadership Transition

Neoleukin Therapeutics Presents Preclinical Data on NEO-TRA1 at American Society of Hematology (ASH) Annual Meeting